Talk:Saxagliptin

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Saxagliptin.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Efficacy[edit]

Agree the efficacy is not impressive, but disagree lack of of impact on CV outcomes merits 2 of the first 5 sentences the article, as competing therapies have zero ornegative CV impact. Lack of weight gain is one of the attractive features of this class and part of why class is so popular, but does not get early mention.Formerly 98 (talk) 17:15, 7 March 2014 (UTC)[reply]

External links modified[edit]

Hello fellow Wikipedians,

I have just added archive links to one external link on Saxagliptin. Please take a moment to review my edit. If necessary, add {{cbignore}} after the link to keep me from modifying it. Alternatively, you can add {{nobots|deny=InternetArchiveBot}} to keep me off the page altogether. I made the following changes:

Added archive https://web.archive.org/20070930160341/http://www.delawareonline.com/apps/pbcs.dll/article?AID=/20070111/BUSINESS/70111024/-1/NLETTER02 to http://www.delawareonline.com/apps/pbcs.dll/article?AID=/20070111/BUSINESS/70111024/-1/NLETTER02

When you have finished reviewing my changes, please set the checked parameter below to true to let others know.

This message was posted before February 2018. After February 2018, "External links modified" talk page sections are no longer generated or monitored by InternetArchiveBot. No special action is required regarding these talk page notices, other than regular verification using the archive tool instructions below. Editors have permission to delete these "External links modified" talk page sections if they want to de-clutter talk pages, but see the RfC before doing mass systematic removals. This message is updated dynamically through the template {{source check}} (last update: 18 January 2022).

If you have discovered URLs which were erroneously considered dead by the bot, you can report them with this tool.
If you found an error with any archives or the URLs themselves, you can fix them with this tool.

Cheers.—^{cyberbot II}_{Talk to my owner:Online} 12:27, 19 February 2016 (UTC)[reply]

Source Quality[edit]

I saw that one of the references included in the article comes from a lawsuit-oriented websited called DrugNews (citation number 11). Since I have a COI with all kind of lawsuits against drug topics, I can't edit it manually, but as far as I know, this kind of reference is against Wiki rules. I suggest either to remove that short sentence altogether, since it does not add any interesting information from an encyclopedic point of view, or to substitute it with another source (I found an article on Medscape "FDA Panel Backs New Safety Warnings on Two Diabetes Drugs" by Alicia Ault) which has a more neutral point of view. Can I do the modifications User:Doc_James ? Daimyo2 (talk) 12:09, 14 June 2016 (UTC)Daimyo2[reply]